Company Directory / Pharmaceuticals

R

Public · NASDAQ:RETAFor profitPharmaceuticalsPlano, Texas, United States

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

Founded
2002
24 years ago
Staff
251-500
103 on LinkedIn
Followers
23k
on LinkedIn
Funding
$2.0B
as listed, USD

Reata Pharmaceuticals has been acquired by Biogen. Please follow along there for the latest news. This page is no longer updated or monitored.

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

251-500 people: larger than 92% of companies with a size listed. 103 people list it on LinkedIn.

Age

200219002026

24 years old.

Reach

No web traffic ranking listed. 23,196 followers on LinkedIn.

What it does

BiopharmaBiotechnologyPharmaceuticalBiopharmaceuticalsResearchClinical OperationsBiotechnology

What it is known for

biopharmaceuticalsresearchclinical operationsbiotechnologylife sciencesbiotechnology: pharmaceutical preparationshealth carepharmaceutical manufacturingpharmaceutical and medicine manufacturingserious diseasesdesigner drugsmedical innovationbiotech companybiotech manufacturingbiotech for rare diseasesbiotech r&d

What its website runs on

Google Search ConsoleApple Business ManagerAWS CloudAmazon CloudFrontZendesk for ServiceAmazon Route 53Apple School ManagerMicrosoft Email ProvidersMicrosoft Exchange OnlineOutlookMicrosoft ExchangeMicrosoft 365Microsoft 365 Apps & ServicesSmartsheetNetSuiteAdobeAmazon AWSDocuSign

Funding, as listed

$2.0B raised in total

  • Rounds16
  • LatestPost ipo debt, May 2023
  • Latest amountUSD 275,000,000
  • Investors10, 7 leading

What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.

FoundersWarren Huff
Apps9
NAICS541714, 325412

Every detail we hold

Everything the source datasets list about Reata Pharmaceuticals, field by field. Contact details are held but never shown.

The company

Name
Reata Pharmaceuticals
Type
For profit
Status
Public · NASDAQ:RETA
Founded
2002
Founders
Warren Huff
Industry
Pharmaceuticals
Categories
Biopharma, Biotechnology, Pharmaceutical
Specialities
Biopharmaceuticals, Research, Clinical Operations, Biotechnology

Where

City
Plano
Region
Texas
Country
United States
Markets
Dallas/Fort Worth Metroplex, Southern US

Size and reach

Staff band
251-500
People on LinkedIn
103
LinkedIn followers
23,196
Apps
9

Funding, as listed

Total
$2,006,204,729 USD
Rounds
16
Latest round
Post ipo debt
Latest round date
May 2023
Latest amount
275,000,000 USD
Investors
10
Lead investors
7
Stock listing
NASDAQ:RETA
Listing status
public

Classification

NAICS
541714, 325412
SIC
2834
Keywords
16 listed, shown above
Technologies
18 detected, shown above

About this record

Sources
Crunchbase, LinkedIn, Apollo
Last imported
Sept 2026

Growth, as the source summarises it

Reata Pharmaceuticals may be growing as it was listed among companies with the best 1-year total returns as of mid-August. This performance indicator suggests that the company's stock value has appreciated, reflecting investor confidence and potentially positive financial health. The inclusion in a list that highlights top returns is indicative of a strong market performance relative to peers, which can be a result of various growth factors such as successful drug developments, effective business strategies, or favorable market conditions.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Pharmaceuticals in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.